Correlation Between Instil Bio and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Unicycive Therapeutics, you can compare the effects of market volatilities on Instil Bio and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Unicycive Therapeutics.
Diversification Opportunities for Instil Bio and Unicycive Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Instil and Unicycive is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Instil Bio i.e., Instil Bio and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Instil Bio and Unicycive Therapeutics
Considering the 90-day investment horizon Instil Bio is expected to generate 1.29 times less return on investment than Unicycive Therapeutics. But when comparing it to its historical volatility, Instil Bio is 1.41 times less risky than Unicycive Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 45.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 24.00 from holding Unicycive Therapeutics or generate 53.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Instil Bio vs. Unicycive Therapeutics
Performance |
| Timeline |
| Instil Bio |
| Unicycive Therapeutics |
Instil Bio and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Instil Bio and Unicycive Therapeutics
The main advantage of trading using opposite Instil Bio and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Instil Bio vs. Assembly Biosciences | Instil Bio vs. Nuvation Bio | Instil Bio vs. Achilles Therapeutics PLC | Instil Bio vs. NextCure |
| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |